MEDICAL DEVICES · SERVICE DETAILS

510(k) submission support

Develop a declaration strategy around substantive equivalence to assist in comparing instrument selection, technical evidence collation, electronic submission and review of responses.

Applicability and scope of work are determined on the basis of products, business activities and available information, and costs and delivery are subject to mutually confirmed project arrangements.

SERVICE OVERVIEW

What does this service help with?

Develop a declaration strategy around substantive equivalence to assist in comparing instrument selection, technical evidence collation, electronic submission and review of responses.

WHO MAY NEED IT

Who should consider this service?

The manufacturer, labeler and team responsible for compliance in the United States market; Specific obligations are judged by the facts of the activities and products of each subject.

SCOPE & APPROACH

What we typically discuss

Identify information gaps before agreeing on documentation and responsibilities.

01

Declaration strategy and contrasting devices

Check classification, intended use, applicable 510(k) type versus legal matching devices, sorting differences and evidentiary plans.

02

Technical material and electronic documents

Combining applicable information such as product recognition, biocompatibility, electrical safety, software, etc.; Tests and clinical work are organized according to actual need and agreement.

03

Communication between submission and review

Organization of declarations in the current applicable format and follow-up to inspections, additional information and responses; The result is a FDA decision and no commitment to obtain clearance.

GET READY

What to prepare before contacting us

If documents are incomplete, share the product and current stage first. You can provide the remaining details later.

  • Technical product paper and intended use
  • Comparing instruments to differential information
  • Labeling, applicable test reports and quality information
HOW TO START

From initial review to engagement

STEP 01

Confirm product and project status

Check products, business roles, existing records and issues to be addressed.

STEP 02

Verification of information and agreed scope

Information gaps, responsibilities of the parties, costs and delivery arrangements are set out on this page.

STEP 03

Undertaking contractual work

Collaboration around the assessment, documentation, submission or maintenance of identified issues to be resolved.

STEP 04

Review and successor arrangements

Delivery of agreed records or recommendations with clear applicable responsibility for subsequent maintenance.

Registration, listing, submission of or obtaining supporting documents from the database does not amount to FDA approval or full compliance determination. The results of the pre-market declaration are determined by the FDA; Specific exemptions, technical and maintenance requirements should be reconciled with products.

TIMING & FEES

Timing and fees

Information reviewed:Fee period: FY 2027, October 1, 2026 through September 30, 2027. For other charges, use the FDA rules as of the review date.

Timing and preparation

Document preparation

(b) Assessment of comparative equipment, performance and other applicable research materials; Test and document supplementation time is taken separately.

FDA processing

The MDUFA V decision target for application of 510(k) is 95 per cent within 90 FDA review days. The FDA review date is not equal to the total project calendar day, and the suspension, testing and business response of the supplementary information will affect the overall cycle.

Fee breakdown

FDA fees

FY 2027 Standard application fee US$28,653; The applicable small business has been identified as US$ 7,163. Eligibility for fee reductions is confirmed before application is submitted, and special circumstances such as third-party review are checked separately.

Service fees

Consulting and filing are quoted separately from FDA fees, based on the number of products, completeness of the records, work scope, response rounds and service term.

Other possible costs

The costs of performance, biocompatibility, electrical safety, software, clinical research or other applicable tests and translation are shown separately by product and are not included in the FDA application fee.

OFFICIAL SOURCES

FDA Official Basis and Check Date

Data check: 2026-11-05. The specific application conditions and submission requirements are based on the current official statement of the FDA and the product facts.

START WITH YOUR PRODUCT

Provide products and current information and confirm the next steps.

Develop a declaration strategy around substantive equivalence to assist in comparing instrument selection, technical evidence collation, electronic submission and review of responses.